1469-896X/asset/olbannerleft.gif?v=1&s=d218899ae53b2862ab119790ed504b8d72122fb3)
1469-896X/asset/olbannerright.gif?v=1&s=59470eb9a1d9b7b13b1be75e9445e6c46ee2214f)
Article
You have full text access to this OnlineOpen article
Conformational flexibility in the apolipoprotein E amino-terminal domain structure determined from three new crystal forms: Implications for lipid binding
Article first published online: 31 DEC 2008
DOI: 10.1110/ps.9.5.886
Copyright © 2000 The Protein Society
1469-896X/asset/cover.gif?v=1&s=0ff483325083001100314f63c633a394aff24478 "Protein Science")
Additional Information
How to Cite
Segelke, B. W., Forstner, M., Knapp, M., Trakhanov, S. D., Parkin, S., Newhouse, Y. M., Bellamy, H. D., Weisgraber, K. H. and Rupp, B. (2000), Conformational flexibility in the apolipoprotein E amino-terminal domain structure determined from three new crystal forms: Implications for lipid binding. Protein Science, 9: 886–897. doi: 10.1110/ps.9.5.886
Publication History
- Issue published online: 31 DEC 2008
- Article first published online: 31 DEC 2008
- Manuscript Accepted: 7 MAR 2000
- Manuscript Revised: 17 FEB 2000
- Manuscript Received: 15 DEC 1999
Funded by
- U.S. Department of Energy. Grant Number: W-7405ENG-48
- National Institutes of Health. Grant Number: NS35939
References
- , . 1996. Methods used in the structure determination of bovine mitochondrial F1 ATPase. Acta Crystallogr D 52: 30–42.
- , , , , . 1988. Human apolipoprotein E3 in aqueous solution. II. Properties of the amino-and carboxyl-terminal domains. J Biol Chem 263: 6249–6258.
- , , , , . 1982. Apoprotein E suppresses phytohemagglutinin-activated phospholipid turnover in peripheral blood mononuclear cells. J Biol Chem 257: 5900–5909.
- , . 1976. Protein crystallography. San Diego: Academic Press. p 565.
- , , , , , , , . 1991. Molecular structure of an apolipoprotein determined at 2.5-Å resolution. Biochemistry 30: 603–608.
- . 1992a. Free R value: A novel statistical quantity for assessing the accuracy of crystal structures. Nature 355: 472–475.
- . 1992b. X-PLOR, Version 3.1. A system for X-ray crystallography and NMR. New Haven, CT: Yale University Press.
- CCP4 (Collaborative Computational Project Number 4). 1994. The CCP4 suite: Programs for protein crystallography. Acta Crystallogr D 50: 760–763. Direct Link:
- . 1997. The SPOCK program manual. SPOCK: The structural properties observation and calculation kit.
- , , , , , , , , . 1993. Gene dose of apoli-poprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261: 921–923.
- , 1996. Phase combination and cross validation in iterated density-modification calculations. Acta Crystallogr D 52: 43–48.
- , 1997. Maximum-likelihood heavy-atom parameter refinement for multiple isomorphous replacement and multiwavelength anomalous diffraction methods. Methods Enzymol 276: 472–494.
- , , , 1995. Comparison of lipid-binding and lecithin:cholesterol acyltransferase activation of the amino-and carboxyl-terminal domains of human apolipoprotein E3. Biochemistry 34: 10953–10960.
- , , , , , , , , . 1996. Novel mechanism for defective receptor binding of apolipoprotein E2 in type III hyperlipopro-teinemia. Nat Struct Biol 3: 718–722.
- , . 1996. Human apolipoprotein E4 domain interaction. Arginine 61 and glutamic acid 255 interact to direct the preference for very low density lipoproteins. J Biol Chem 271: 19053–19057.
- , , , , , , . 1994. Human apolipoprotein E. Role of arginine 61 in mediating the lipoprotein preferences of the E3 and E4 isoforms. J Biol Chem 269: 22358–22365.
- , , , , , , . 1993. Relation of apolipoprotein E phenotype to myocardial infarction and mortality from coronary artery disease. Am J Cardiol 71: 160–165.
- , , , 1988. The MIDAS display system. J Mol Graph 6: 13–27.
- , , , , , , . 1999. Carboxyl-terminal domain of human apo-lipoprotein E: Expression, purification, and crystallization. Protein Expr Purif 17: 267–272.
- 1985. Multiwire area X-ray diffractometers. Methods Enzymol 114: 416–452.
- , , . 1994. Four helix bundle diversity in globular proteins. J Mol Biol 236: 1356–1368.
- , . 1997. Phase determination from multiwavelength anomalous diffraction measurements. Methods Enzymol 276: 494–516.
- , , . 1985. Software for a diffractometer with multiwire area detector. Methods Enzymol 114: 452–472.
- , , , . 1980. Immunoregulatory plasma lipoproteins. Role of apoprotein E and apoprotein B. J Biol Chem 255: 11775–11781.
- , , , , . 1983. The receptor-binding domain of human apolipoprotein E. Binding of apolipoprotein E fragments. J Biol Chem 258: 12341–12347.
- , , . 1979. Binding of arginine-rich E apoprotein after recombination with phospholipid vesicles to the low density lipo-protein receptors of fibroblasts. J Biol Chem 254: 4186–4190.
- , , , . 1998. Apolipoprotein E inhibits platelet-derived growth factor-induced vascular smooth muscle cell migration and proliferation by suppressing signal transduction and preventing cell entry to G1 phase. J Biol Chem 273: 20156–20161.
- 1988. Evaluation of single-crystal X-ray diffraction data from a position-sensitive detector. J Appl Crystallogr 21: 916–924.
- , , . 1999. Rapid automated molecular replacement by evolutionary search. Acta Crystallogr D 55: 484–491.
- . 1991. MOLSCRIPT: A program to produce both detailed and schematic plots of protein structures. J Appl Crystallogr 24: 946–950.
- , . 1993. Automated refinement of protein models. Acta Crystallogr D 49: 129–147.
- , . 1985. 1H-15N heteronuclear NMR studies of Escherichia coli thioredoxin in samples isotopically labeled by residue type. Biochemistry 24: 7263–7268.
- , , , , , , , , , , , 1994. Impact of apolipoprotein E polymorphism on lipoproteins and risk of myo-cardial infarction. The ECTIM study. Arterioscler Thromb 14: 1412–1419.
- 1953. Resolution d'une structure cristalline lorsque les positions d'une partie des atomes sont connues: Traitement statistique. Acta Crystallogr 6: 142–152.
- . 1988. Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology. Science 240: 622–630.
- , 1995. Type III hyperlipoproteinemia (dysbetalipopro-teinemia): The role of apolipoprotein E in normal and abnormal lipoprotein metabolism. In: ScriverCR, BeaudetAL, SlyWS, ValleD, eds. The metabolic and molecular bases of inherited disease, 7th ed. New York: McGraw-Hill. pp 1953–1980.
- , , , , , , , , 1995. Synergistic effects of traumatic head injury and apolipoprotein-e4 in patients with Alzheimer's disease. Neurology 45: 555–557.
- 1982. Preparation and analysis of protein crystals, New York: John Wiley & Sons.
- . 1992. A visual protein crystallographic software system for X11/Xview. J Mol Graph 10: 44–46.
- , . 1997. Raster3D: Photorealistic molecular graphics. Methods Enzymol 277: 505–524.
- , , . 1997. Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr D 53: 240–255.
- , , , , . 1996. Disulfide bond engineering to monitor conformational opening of apolipophorin III during lipid binding. J Biol Chem 271: 26855–26862.
- , , , , . 1999. A molecular trigger of lipid binding-induced opening of a helix bundle exchangeable apolipoprotein. Proc Natl Acad Sci USA 96: 4366–4371.
- , 1997. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol 276: 307–326.
- , 1998. Macromolecular cryocrystallography: Cooling, mounting, storage and transportation of crystals. J Appl Crystallogr 31: 945–953.
- , , , . 1997. wARP: Improvement and extension of crystallographic phases by weighted averaging of multiple-refined dummy atomic models. Acta Crystallogr D 53: 448–455.
- , , , , , , , , , 1995. Molecular characterization of two monoclonal antibodies specific for the LDL receptor-binding site of human apolipoprotein E. J Lipid Res 36: 1905–1918.
- , . 1992. The role of apolipoprotein E genetic variants in lipoprotein disorders. J Intern Med 231: 653–659
- , , . 1982. Human apolipoprotein E. The complete amino acid sequence. J Biol Chem 257: 4171–4178.
- , , 1963. Stereochemistry of polypeptide chain configurations. J Mol Biol 7: 95–99.
- , , , , 1998. The low density lipoprotein receptor active conformation of apolipoprotein E. Helix organization in N-terminal domain-phospholipid disc particles. J Biol Chem 273: 25825–25830.
- , . 1991. Suppression of cAMP-mediated signal transduction in mouse adrenocortical cells which express apolipoprotein E. J Biol Chem 266: 21099–21104.
- , , , , , , , , , , et al. 1993. Association of apolipoprotein E allele e4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43: 1467–1472.
- , , , , 1993. Primary structure and crystallization of orotate phosphoribosyltransferase fro Salmonella typhimurium. J Mol Biol 230: 1304–1308.
- , , , , . 1994. The amphipathic a helix: A multifunctional structural motif in plasma apolipoproteins. Adv Protein Chem 45: 303–369.
- , , , , , . 1992. The amphipathic helix in the exchangeable apolipoproteins: A review of secondary structure and function. J Lipid Res 33: 141–166.
- , , , , , , , , , , et al. 1997. Apolipoprotein E4 and the risk of dementia with stroke. A population-based investigation. J Am Med Assoc 277: 818–821.
- , , , , , , . 1993. Apolipoprotein E: High-avidity binding to b-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA 90: 1977–1981.
- , . 1986. Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes. J Mol Biol 189: 113–130.
- , , , 1997. Association of apolipoprotein E polymorphism with outcome after head injury. Lancet 350: 1069–1071.
- , 1999. Automated MAD and MIR structure solution. Acta Crystallogr D 55: 849–861.
- , , , , , , 1999. Structure of a monoclonal 2E8 Fab antibody fragment specific for the low-density lipoprotein-receptor binding region of apolipoprotein E refined at 1.9 Å. Acta Crystallogr D 55: 122–128.
- , , 1984. Apolipoprotein E phenotypes in patients with myocardial infarction. Hum Genet 65: 237–241.
- , , , , , , , , , , et al. 1985. Human apolipoprotein E expression in Escherichia coli: Structural and functional identity of the bacterially produced protein with plasma apolipoprotein E. Proc Natl Acad Sci USA 82: 8696–8700.
- 1990. WHAT IF: A molecular modeling and drug design program. J Mol Graphics 8: 52–56.
- , , , . 1997. Insight into lipid surface recognition and reversible conformational adaptations of an exchangeable apolipoprotein by multidimensional heteronuclear NMR techniques. J Biol Chem 272: 17912–17920.
- . 1990. Apolipoprotein E distribution among human plasma lipoproteins: Role of the cysteine-arginine interchange at residue 112. J Lipid Res 31: 1503–1511.
- . 1994. Apolipoprotein E: Structure-function relationships. Adv Protein Chem 45: 249–302.
- , , . 1992. Apolipoprotein E: Structure-function correlations. In: MillerNE, TallAR, eds. High density lipoproteins and atherosclerosis III. Amsterdam: Elsevier Science Publishers. pp 175–181.
- , , . 1981. Human E apoprotein heteroge-neity. Cysteine-arginine interchanges in the amino acid sequence of the apo-E isoforms. J Biol Chem 256: 9077–9083.
- , , , . 1988. Human apoli-poprotein E3 in aqueous solution. I. Evidence for two structural domains. J Biol Chem 263: 6240–6248.
- , , , , , . 1994. Salt bridge relay triggers defective LDL receptor binding by a mutant apo-lipoprotein. Structure 2: 713–718.
- , , , , . 1991. Three-dimensional structure of the LDL receptor-binding domain of human apolipoprotein E. Science 252: 1817–1822.
- , , , , , . 1997. Crystal structure of mouse CD1: An MHC-like fold with a large hydrophobic binding groove. Science 277: 339–345.